Ancora Advisors, LLC Applied Genetic Technologies Corp Transaction History

Ancora Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$2.28 - $7.15 $171,378 - $537,436	-75,166 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$3.85 - $7.35 $2,429 - $4,637	631 Added 0.85%	75,166 $549,000
Q2 2018 Aug 10, 2018	BUY	$3.7 - $5.65 $1,409 - $2,152	381 Added 0.51%	74,535 $276,000
Q1 2018 May 15, 2018	BUY	$3.65 - $5.2 $197,662 - $281,600	54,154 Added 270.77%	74,154 $285,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.25 $71,000 - $105,000	20,000	20,000 $79,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.